To identify the relationship between the clinicopathological features and methylation status of ZNF545 in breast tumorigenesis, and to develop biomarkers for breast cancer detection and prognosis, ZNF545 methylation was examined in 29% of primary breast tumor tissues, but not in normal tissues, consistent with our previous study [14]. This evidence concerns the gene ZFP82 and breast cancer.